Helping an older adult stay consistent with breathing treatments can feel like a full-time job - especially when COPD, asthma, or chronic congestion is already draining their energy. A nebulizer can ...
Redd’s daily treatment reveals how orangutans with chronic respiratory diseases are adapting to use certain medical tools ...
Some healthcare and nursery workers may be given antibiotics within three weeks of the cough starting. The final cough on Dr ...
The scope of all human knowledge is, understandably, so massive that no one person can manage to fully comprehend even a ...
As of Monday, December 15, Quipt Home Medical Corp.’s QIPT share price has surged by 34.67%, which has investors questioning if this is right time to sell.
In March 2025, Japan’s Ministry of Health, Labour and Welfare has approved the marketing and manufacturing of Dupixent ...
LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) said members of its management team will present and hold one-on-one meetings at ...
COPD inhaled triple therapy (BDP/FF/G) improved symptoms, lung function, adherence, and QOL in patients previously treated with inhaled dual therapy.
Dear Dr. Roach: In a recent column, you noted that many patients do not properly use their inhaled asthma/chronic obstructive pulmonary disease (COPD) medications, but you didn't tell us how to ...
The U.S. Food and Drug Administration has approved Jascayd (nerandomilast) tablets for the treatment of progressive pulmonary ...
The FDA has approved Jascayd (nerandomilast) as a treatment for a second lung disease, progressive pulmonary fibrosis, following the drug’s initial approval in October 2025 as a treatment for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback